KoBioLabs, Inc (KOSDAQ:348150)
South Korea · Delayed Price · Currency is KRW 4,750.00
+245.00 (5.44%)
At close: Mar 12, 2026
KoBioLabs Market Cap
KoBioLabs has a market cap or net worth of 92.24 billion as of March 12, 2026. Its market cap has decreased by -0.19% in one year.
Market Cap
92.24B
Enterprise Value
74.04B
Revenue
71.83B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,750.00
Market Cap Chart
Since November 18, 2020, KoBioLabs's market cap has decreased from 493.16B to 92.24B, a decrease of -81.30%. That is a compound annual growth rate of -27.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 92.24B | -17.10% |
| Dec 30, 2025 | 111.27B | 7.15% |
| Dec 30, 2024 | 103.84B | -35.34% |
| Dec 28, 2023 | 160.60B | -16.02% |
| Dec 29, 2022 | 191.23B | -42.95% |
| Dec 30, 2021 | 335.17B | -50.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NovMetaPharma | 114.03B |
| Quratis | 104.44B |
| Cell Biotech | 99.99B |
| TegoScience | 96.32B |
| CTCBIO | 94.92B |
| Progen | 94.71B |
| Choong Ang Vaccine Laboratory | 86.93B |
| CHA Vaccine Research Institute | 86.10B |